Published research showed that excavatolide B (2.5 and 5 mg/kg, s.c.)in adjuvant (AIA) and type II collagen-induced arthritis in rats attenuate the protein expression of CD11b and nuclear factor of activated T cells 1 (NFATc1) in ankle tissues [75]. The gene discussed is NFATC1; the disease is arthritic joint disease.